603351 威尔药业
已收盘 12-16 15:00:00
资讯
新帖
简况
威尔药业（603351）披露关于完成工商备案登记的公告，12月4日股价下跌1.54%
证券之星 · 12-04
威尔药业（603351）披露关于完成工商备案登记的公告，12月4日股价下跌1.54%
每周股票复盘：威尔药业（603351）取消监事会获股东会通过
证券之星 · 11-16
每周股票复盘：威尔药业（603351）取消监事会获股东会通过
每周股票复盘：威尔药业（603351）拟取消监事会
证券之星 · 11-09
每周股票复盘：威尔药业（603351）拟取消监事会
威尔药业（603351）披露拟取消监事会并由董事会审计委员会行使监事会职权，11月06日股价上涨1.3%
证券之星 · 11-06
威尔药业（603351）披露拟取消监事会并由董事会审计委员会行使监事会职权，11月06日股价上涨1.3%
每周股票复盘：威尔药业（603351）Q3净利增21.46%
证券之星 · 11-02
每周股票复盘：威尔药业（603351）Q3净利增21.46%
威尔药业(603351)9月30日股东户数0.68万户，较上期增加5.36%
证券之星 · 10-30
威尔药业(603351)9月30日股东户数0.68万户，较上期增加5.36%
图解威尔药业三季报：第三季度单季净利润同比增长21.46%
证券之星 · 10-29
图解威尔药业三季报：第三季度单季净利润同比增长21.46%
每周股票复盘：威尔药业（603351）股东减持135.43万股占总股本0.9999%
证券之星 · 10-26
每周股票复盘：威尔药业（603351）股东减持135.43万股占总股本0.9999%
威尔药业（603351）披露股东集中竞价减持股份结果公告，10月23日股价下跌0.33%
证券之星 · 10-23
威尔药业（603351）披露股东集中竞价减持股份结果公告，10月23日股价下跌0.33%
每周股票复盘：威尔药业（603351）高正松质押展期至2026年8月21日
证券之星 · 08-31
每周股票复盘：威尔药业（603351）高正松质押展期至2026年8月21日
山西证券：给予威尔药业买入评级
证券之星 · 08-26
山西证券：给予威尔药业买入评级
每周股票复盘：威尔药业（603351）股东户数增加1419户，归母净利润下降7.77%
证券之星 · 08-24
每周股票复盘：威尔药业（603351）股东户数增加1419户，归母净利润下降7.77%
威尔药业（603351）2025年中报简析：净利润同比下降7.77%
证券之星 · 08-21
威尔药业（603351）2025年中报简析：净利润同比下降7.77%
威尔药业（603351）股东唐群松质押315万股，占总股本2.33%
证券之星 · 08-20
威尔药业（603351）股东唐群松质押315万股，占总股本2.33%
威尔药业：2025年上半年净利润7276.69万元，同比下降7.77%
金融界 · 08-19
威尔药业：2025年上半年净利润7276.69万元，同比下降7.77%
威尔药业：股东陈新国、唐群松及舜泰宗华进行股份质押及解质押
金融界 · 08-18
威尔药业：股东陈新国、唐群松及舜泰宗华进行股份质押及解质押
威尔药业中标中石化聚醚项目 券商买入评级彰显成长潜力
自选股中标信息 · 08-08
威尔药业中标中石化聚醚项目 券商买入评级彰显成长潜力
南京威尔药业集团股份有限公司中标中国石化润滑油有限公司上海研究院项目
DoNews · 08-07
南京威尔药业集团股份有限公司中标中国石化润滑油有限公司上海研究院项目
威尔药业中标中石化酯类项目 券商看好买入评级股价上扬
自选股中标信息 · 08-05
威尔药业中标中石化酯类项目 券商看好买入评级股价上扬
威尔药业股价微涨0.71% 盘中现快速波动
金融界 · 08-05
威尔药业股价微涨0.71% 盘中现快速波动
加载更多
公司概况
公司名称：
南京威尔药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2019-01-30
主营业务：
南京威尔药业集团股份有限公司的主营业务是药用辅料及合成润滑基础油产品的研发、生产和销售。公司的主要产品是药用辅料、合成润滑基础油。经江苏省经济和信息化委员会鉴定，公司聚山梨酯80（供注射用）产品“生产技术达到国际先进水平”，难燃液压液用酯类基础油、难燃液压液用水溶性高分子聚醚、高压乙烯压缩机油用醚类基础油等产品“生产技术达到国内领先水平”。
发行价格：
35.50
{"stockData":{"symbol":"603351","market":"SH","secType":"STK","nameCN":"威尔药业","latestPrice":25.69,"timestamp":1765868401000,"preClose":26.22,"halted":0,"volume":670212,"delay":0,"changeRate":-0.0202,"floatShares":135000000,"shares":135000000,"eps":1.0898,"marketStatus":"已收盘","change":-0.53,"latestTime":"12-16 15:00:00","open":26.34,"high":26.34,"low":25.44,"amount":17208400,"amplitude":0.0343,"askPrice":25.69,"askSize":1,"bidPrice":25.61,"bidSize":9,"shortable":0,"etf":0,"ttmEps":1.0898,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765935000000},"marketStatusCode":5,"adr":0,"adjPreClose":26.22,"symbolType":"stock","openAndCloseTimeList":[[1765848600000,1765855800000],[1765861200000,1765868400000]],"highLimit":28.84,"lowLimit":23.6,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":135439132,"isCdr":false,"pbRate":1.98,"roa":"--","peRate":23.573133,"roe":"6.55%","epsLYR":1.08,"committee":0.868354,"marketValue":3479000000,"turnoverRate":0.0049,"status":1,"floatMarketCap":3479000000},"requestUrl":"/m/hq/s/603351","defaultTab":"news","newsList":[{"id":"2588884838","title":"威尔药业（603351）披露关于完成工商备案登记的公告，12月4日股价下跌1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588884838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588884838?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:30","pubTimestamp":1764858645,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘，威尔药业报收于26.84元，较前一交易日下跌1.54%，最新总市值为36.35亿元。该股当日开盘27.11元，最高27.2元，最低26.4元，成交额达3017.34万元，换手率为0.83%。近日，威尔药业发布关于完成工商备案登记的公告。公告显示，南京威尔药业集团股份有限公司于2025年10月29日召开第三届董事会第十三次会议，并于2025年11月14日召开2025年第一次临时股东大会，审议通过取消监事会并修订《公司章程》的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400039802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0275","BK0239"],"gpt_icon":0},{"id":"2583651544","title":"每周股票复盘：威尔药业（603351）取消监事会获股东会通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2583651544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583651544?lang=zh_cn&edition=full","pubTime":"2025-11-16 03:26","pubTimestamp":1763234774,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，威尔药业报收于30.12元，较上周的28.71元上涨4.91%。本周关注点公司公告汇总：威尔药业股东大会通过取消监事会并修订公司章程的议案。南京威尔药业集团股份有限公司于2025年11月14日召开2025年第一次临时股东大会，会议由董事会召集，吴仁荣主持，采用现场与网络投票结合方式举行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0239","BK0275"],"gpt_icon":0},{"id":"2582861036","title":"每周股票复盘：威尔药业（603351）拟取消监事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2582861036","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582861036?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:25","pubTimestamp":1762633512,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，威尔药业报收于28.71元，较上周的28.92元下跌0.73%。本周，威尔药业11月7日盘中最高价报29.17元。本周关注点公司公告汇总：威尔药业拟取消监事会，由董事会审计委员会行使监事会职权。公司公告汇总威尔药业2025年第一次临时股东大会会议资料南京威尔药业集团股份有限公司拟取消监事会，不再设监事，由董事会审计委员会行使监事会职权，并废止《监事会议事规则》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0275","603351"],"gpt_icon":0},{"id":"2581509456","title":"威尔药业（603351）披露拟取消监事会并由董事会审计委员会行使监事会职权，11月06日股价上涨1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581509456","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581509456?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:33","pubTimestamp":1762439604,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，威尔药业报收于28.84元，较前一交易日上涨1.3%，最新总市值为39.06亿元。根据近日发布的《威尔药业2025年第一次临时股东大会会议资料》，南京威尔药业集团股份有限公司拟取消监事会，不再设监事，由董事会审计委员会行使监事会职权，并废止《监事会议事规则》。此外，公司还计划修订股东会议事规则、董事会议事规则、独立董事工作制度等多项治理制度，部分制度修订尚需提交股东大会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600038379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0275","603351","BK0239"],"gpt_icon":0},{"id":"2580423470","title":"每周股票复盘：威尔药业（603351）Q3净利增21.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580423470","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580423470?lang=zh_cn&edition=full","pubTime":"2025-11-02 08:19","pubTimestamp":1762042755,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，威尔药业报收于28.92元，较上周的27.43元上涨5.43%。股本股东变化截至2025年9月30日，威尔药业股东户数为6776户，较6月30日增加345户，增幅5.36%。业绩披露要点威尔药业2025年三季报显示，前三季度主营收入10.18亿元，同比上升1.79%；归母净利润1.14亿元，同比上升1.03%；扣非净利润1.1亿元，同比上升6.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0239","BK0275"],"gpt_icon":0},{"id":"2579190073","title":"威尔药业(603351)9月30日股东户数0.68万户，较上期增加5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579190073","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579190073?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:21","pubTimestamp":1761816118,"startTime":"0","endTime":"0","summary":"证券之星消息，近日威尔药业披露，截至2025年9月30日公司股东户数为6776.0户，较6月30日增加345.0户，增幅为5.36%。在化学制药行业个股中，威尔药业股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.43万户。从股价来看，2025年6月30日至2025年9月30日，威尔药业区间涨幅为2.61%，在此期间股东户数增加345.0户，增幅为5.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000032677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0275","BK0239","603351"],"gpt_icon":0},{"id":"2579707609","title":"图解威尔药业三季报：第三季度单季净利润同比增长21.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579707609","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579707609?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:46","pubTimestamp":1761738362,"startTime":"0","endTime":"0","summary":"证券之星消息，威尔药业2025年三季报显示，前三季度公司主营收入10.18亿元，同比上升1.79%；归母净利润1.14亿元，同比上升1.03%；扣非净利润1.1亿元，同比上升6.97%；其中2025年第三季度，公司单季度主营收入3.45亿元，同比上升10.35%；单季度归母净利润4129.86万元，同比上升21.46%；单季度扣非净利润3822.07万元，同比上升12.8%；负债率31.69%，投资收益1.54万元，财务费用793.74万元，毛利率28.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900040530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351"],"gpt_icon":0},{"id":"2578500455","title":"每周股票复盘：威尔药业（603351）股东减持135.43万股占总股本0.9999%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578500455","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578500455?lang=zh_cn&edition=full","pubTime":"2025-10-26 04:43","pubTimestamp":1761424987,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，威尔药业报收于27.43元，较上周的28.08元下跌2.31%。该股东为公司员工持股平台，减持前持股7.49%。当前持股数量为8,788,699股，占总股本6.49%。威尔药业关于持股5%以上股东权益变动触及1%刻度的提示性公告南京威尔药业集团股份有限公司公告，信息披露义务人南京舜泰宗华创业投资合伙企业及其一致行动人吴仁荣、高正松、陈新国在2025年8月20日至10月22日期间，通过集中竞价减持公司股份1,354,291股，占总股本1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0275","BK0239"],"gpt_icon":0},{"id":"2577585633","title":"威尔药业（603351）披露股东集中竞价减持股份结果公告，10月23日股价下跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577585633","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577585633?lang=zh_cn&edition=full","pubTime":"2025-10-23 22:37","pubTimestamp":1761230230,"startTime":"0","endTime":"0","summary":"近日，南京威尔药业集团股份有限公司发布股东集中竞价减持股份结果公告。股东南京舜泰宗华创业投资合伙企业为公司员工持股平台，减持前持有公司股份10,142,990股，占总股本的7.49%。原计划自2025年8月20日至11月17日通过集中竞价方式减持不超过1,354,390股。截至公告日，舜泰宗华已实际减持1,354,291股，减持价格区间为26.62～31.32元/股，减持总金额38,184,450.82元，当前持股数量为8,788,699股，占总股本的6.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300037939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0275","603351","BK0239"],"gpt_icon":0},{"id":"2563834867","title":"每周股票复盘：威尔药业（603351）高正松质押展期至2026年8月21日","url":"https://stock-news.laohu8.com/highlight/detail?id=2563834867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563834867?lang=zh_cn&edition=full","pubTime":"2025-08-31 13:18","pubTimestamp":1756617492,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，威尔药业报收于29.01元，较上周的30.05元下跌3.46%。本周，威尔药业8月26日盘中最高价报30.5元。8月28日盘中最低价报28.35元。威尔药业当前最新总市值39.29亿元，在化学制药板块市值排名122/150，在两市A股市值排名3901/5152。高正松和唐群松分别解质211万股和260万股，解质时间为2025年8月22日。公司控股股东及其一致行动人累计质押股份由2523万股减少至2312万股，占其所持股份比例为40.65%，占公司总股本比例为17.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100004638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0239","BK0275"],"gpt_icon":0},{"id":"2562872007","title":"山西证券：给予威尔药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2562872007","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562872007?lang=zh_cn&edition=full","pubTime":"2025-08-26 18:31","pubTimestamp":1756204307,"startTime":"0","endTime":"0","summary":"山西证券股份有限公司邓周宇,魏赟,李旋坤,王金源近期对威尔药业进行研究并发布了研究报告《合成润滑基础油与药辅双轮驱动，布局战略性新兴行业》，给予威尔药业买入评级。在冷冻压缩机油领域，产品广泛应用于终端头部用户，受益于工商业制冷、新能源汽车的市场需求增长。首次覆盖，给予“买入-B”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082600040118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","002500"],"gpt_icon":0},{"id":"2561557752","title":"每周股票复盘：威尔药业（603351）股东户数增加1419户，归母净利润下降7.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561557752","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561557752?lang=zh_cn&edition=full","pubTime":"2025-08-24 08:02","pubTimestamp":1755993745,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，威尔药业报收于30.05元，较上周的30.81元下跌2.47%。本周，威尔药业8月18日盘中最高价报32.95元。本周关注点股本股东变化：股东户数较3月31日增加1419.0户，增幅为28.31%业绩披露要点：归母净利润7276.69万元，同比下降7.77%股本股东变化近日威尔药业披露，截至2025年6月30日公司股东户数为6431.0户，较3月31日增加1419.0户，增幅为28.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400002289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351"],"gpt_icon":0},{"id":"2561482759","title":"威尔药业（603351）2025年中报简析：净利润同比下降7.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561482759","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561482759?lang=zh_cn&edition=full","pubTime":"2025-08-21 06:04","pubTimestamp":1755727442,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期威尔药业发布2025年中报。根据财报显示，威尔药业净利润同比下降7.77%。截至本报告期末，公司营业总收入6.74亿元，同比下降2.1%，归母净利润7276.69万元，同比下降7.77%。按单季度数据看，第二季度营业总收入3.24亿元，同比下降9.58%，第二季度归母净利润3617.93万元，同比下降18.32%。应付账款变动幅度为29.72%,原因:原材料货款及工程款增加。应交税费变动幅度为70.17%,原因:计提应交增值税及所得税。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082100002606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351"],"gpt_icon":0},{"id":"2560174401","title":"威尔药业（603351）股东唐群松质押315万股，占总股本2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560174401","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560174401?lang=zh_cn&edition=full","pubTime":"2025-08-20 18:24","pubTimestamp":1755685469,"startTime":"0","endTime":"0","summary":"证券之星消息，威尔药业8月20日公开信息显示，股东唐群松向中国银河证券股份有限公司合计质押315.0万股，占总股本2.33%。威尔药业主营业务：专注于药用辅料及合成润滑基础油产品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082000037039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0275","603351"],"gpt_icon":0},{"id":"2560613371","title":"威尔药业：2025年上半年净利润7276.69万元，同比下降7.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560613371","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560613371?lang=zh_cn&edition=full","pubTime":"2025-08-19 16:39","pubTimestamp":1755592790,"startTime":"0","endTime":"0","summary":"威尔药业公告，2025年上半年营业收入6.74亿元，同比下降2.10%。净利润7276.69万元，同比下降7.77%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/19163952534332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["603351"],"gpt_icon":0},{"id":"2560463970","title":"威尔药业：股东陈新国、唐群松及舜泰宗华进行股份质押及解质押","url":"https://stock-news.laohu8.com/highlight/detail?id=2560463970","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560463970?lang=zh_cn&edition=full","pubTime":"2025-08-18 16:55","pubTimestamp":1755507328,"startTime":"0","endTime":"0","summary":"威尔药业公告，近日获悉公司5%以上股东陈新国、唐群松及南京舜泰宗华创业投资合伙企业所持有的公司股份质押及解质押。其中，陈新国质押450万股，占其所持股份比例31.89%，占公司总股本比例3.32%；唐群松质押385万股，占其所持股份比例27.28%，占公司总股本比例2.84%；舜泰宗华质押370万股，占其所持股份比例36.48%，占公司总股本比例2.73%。此外，陈新国和唐群松分别解质535万股和480万股，占公司总股本比例3.95%和3.54%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/18165552505582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0275","BK0239","603351"],"gpt_icon":0},{"id":"2557528514","title":"威尔药业中标中石化聚醚项目 券商买入评级彰显成长潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2557528514","media":"自选股中标信息","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557528514?lang=zh_cn&edition=full","pubTime":"2025-08-08 18:14","pubTimestamp":1754648094,"startTime":"0","endTime":"0","summary":"2025年08月08日，据天眼查数据，中国石化润滑油有限公司润滑油公司2025年13个聚醚招标聚醚\\SDN-10D工业级招标结果公告显示，中标方为威尔药业，招标方为中国石化润滑油有限公司润滑油公司。近半年内，威尔药业获得1家券商积极评价：申万宏源研究给予\"买入\"评级。威尔药业主营业务涵盖合成润滑基础油(机械类)，合成润滑基础油，药用辅料，其他收入之和。截至发稿，威尔药业股价报31.5元，上涨0.38%，成交额至4848.25万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808181459a6dad40e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808181459a6dad40e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603351"],"gpt_icon":0},{"id":"2557016053","title":"南京威尔药业集团股份有限公司中标中国石化润滑油有限公司上海研究院项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2557016053","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557016053?lang=zh_cn&edition=full","pubTime":"2025-08-07 02:29","pubTimestamp":1754504943,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年8月5日，中国石化润滑油有限公司上海研究院发布了润滑油上海研究院2025年醚类SDN-165询比采购预成交公示。公告显示，此次中标供应商为南京威尔药业集团股份有限公司，中标金额为93600.0元。本次公告类型为中标结果，项目地点位于上海市。公示时间从2025年8月5日23:09至2025年8月8日23:09。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070229389737f48d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070229389737f48d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0000","BK0188","BK0196","600028","BK0010","BK0015","BK0275","BK0006","BK0012","LU1051768304.USD","BK0025","603351","BK0176","BK0028","BK0183","LU0651946864.USD","LU1580142542.USD","BK0239","BK0274","LU1781817850.SGD","LU1515016050.SGD"],"gpt_icon":0},{"id":"2557360087","title":"威尔药业中标中石化酯类项目 券商看好买入评级股价上扬","url":"https://stock-news.laohu8.com/highlight/detail?id=2557360087","media":"自选股中标信息","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557360087?lang=zh_cn&edition=full","pubTime":"2025-08-05 18:21","pubTimestamp":1754389262,"startTime":"0","endTime":"0","summary":"2025年08月05日，据天眼查数据，润滑油公司2025年偏苯异辛醇酯公开招标酯类/偏苯异辛醇酯(98%)工业级中标结果公告显示，中标方为威尔药业，招标方为中国石化国际事业有限公司。近半年内，威尔药业获得1家券商积极评价：申万宏源研究给予\"买入\"评级。威尔药业主营业务涵盖合成润滑基础油(机械类)，合成润滑基础油，药用辅料，其他收入之和。截至发稿，威尔药业股价报31.86元，上涨2.12%，成交额至1.10亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805182112a47665f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805182112a47665f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603351"],"gpt_icon":0},{"id":"2557354383","title":"威尔药业股价微涨0.71% 盘中现快速波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2557354383","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557354383?lang=zh_cn&edition=full","pubTime":"2025-08-05 01:49","pubTimestamp":1754329780,"startTime":"0","endTime":"0","summary":"截至2025年8月4日收盘，威尔药业报31.20元，较前一交易日上涨0.22元。该股当日振幅达2.87%，盘中出现快速波动，早盘时段先后出现5分钟内涨幅超2%和跌幅超2%的走势。全天成交量为30375手，成交金额0.93亿元。威尔药业属于化学制药行业，公司主要从事药用辅料及合成润滑基础油的研发、生产和销售。公司产品广泛应用于医药制剂、食品、化妆品等领域。从资金流向来看，威尔药业8月4日主力资金净流出130.51万元，但近五个交易日整体呈现净流入状态，累计净流入376.62万元。风险提示：股市有风险，投资需谨慎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080502005194cf5be8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080502005194cf5be8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0275","BK0239","603351"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765887788401,"stockEarnings":[{"period":"1week","weight":-0.0371},{"period":"1month","weight":-0.1295},{"period":"3month","weight":-0.0842},{"period":"6month","weight":-0.0091},{"period":"1year","weight":0.1002},{"period":"ytd","weight":0.0828}],"compareEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":-0.0307},{"period":"3month","weight":0.0016},{"period":"6month","weight":0.1414},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.154}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京威尔药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6776人(较上一季度增加5.36%)","perCapita":"19988股","listingDate":"2019-01-30","address":"江苏省南京市六合区南京化学工业园区长丰河西路99号","registeredCapital":"13543万元","survey":" 南京威尔药业集团股份有限公司的主营业务是药用辅料及合成润滑基础油产品的研发、生产和销售。公司的主要产品是药用辅料、合成润滑基础油。经江苏省经济和信息化委员会鉴定，公司聚山梨酯80（供注射用）产品“生产技术达到国际先进水平”，难燃液压液用酯类基础油、难燃液压液用水溶性高分子聚醚、高压乙烯压缩机油用醚类基础油等产品“生产技术达到国内领先水平”。","listedPrice":35.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"威尔药业(603351)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供威尔药业(603351)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"威尔药业,603351,威尔药业股票,威尔药业股票老虎,威尔药业股票老虎国际,威尔药业行情,威尔药业股票行情,威尔药业股价,威尔药业股市,威尔药业股票价格,威尔药业股票交易,威尔药业股票购买,威尔药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"威尔药业(603351)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供威尔药业(603351)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}